Projects and Progress

No one knows for sure, but world-wide around 10 million people have Parkinson's. Currently the only treatments available are symptomatic i.e. they ease symptoms on a day by day basis but none of them slow the neurological decline of Parkinson's on a year by year basis. Levodopa, introduced  as a symptomatic treatment in the 1960's, was a game-changer in that it transformed the day to day management of the condition.

Now, nearly sixty years on, new understanding about the nature of the condition, plus attempts to match a range of innovative therapies to the emerging science is finally starting to change prospects for people with Parkinson's.

Please help us in our drive to slow, stop, or reverse this condition. Donate now - thank you.